IAA19 Antibody

What is IAA19 and why is it important in plant biology research?

IAA19 is an auxin-sensitive repressor protein belonging to the Aux/IAA family that plays critical roles in plant development and stress responses. These proteins function as active repressors by dimerizing with auxin response factors (ARFs) bound to auxin response elements, thereby regulating gene expression . IAA19 specifically has been implicated in stress tolerance mechanisms and auxin signaling pathways that regulate root development and other physiological processes . Understanding IAA19 function is essential for deciphering plant adaptation to environmental stresses and developmental plasticity. The protein contains conserved domains including domain I (repression domain), domain II (degron responsible for auxin-mediated degradation), and domains III/IV (dimerization domains) .

How do IAA19 antibodies differ from other Aux/IAA protein antibodies?

IAA19 antibodies are specifically designed to recognize epitopes unique to the IAA19 protein, distinguishing it from other Aux/IAA family members. While Aux/IAA proteins share conserved domains, they differ in their N-terminal regions and in specific amino acid sequences within the conserved domains. High-quality IAA19 antibodies target unique regions of the protein sequence to minimize cross-reactivity with related family members like IAA2, IAA5, IAA6, and IAA9 . When selecting an IAA19 antibody, researchers should review the immunogen sequence used for antibody production and validation data demonstrating specificity against other Aux/IAA proteins. Cross-reactivity testing is particularly important since IAA19 shares up to 60-70% sequence homology with some family members in conserved domains.

What are the recommended storage conditions for IAA19 antibodies?

For optimal stability and functionality, IAA19 antibodies should be stored according to manufacturer guidelines, which typically involve aliquoting to avoid repeated freeze-thaw cycles. Most IAA19 antibodies should be stored at -20°C for long-term storage, with working aliquots kept at 4°C for up to one month. The addition of preservatives such as sodium azide (0.02%) to antibody solutions can help prevent microbial contamination during storage. Researchers should monitor antibody performance over time through regular validation tests, as antibody functionality can diminish with improper storage. For monoclonal antibodies against IAA19, stability testing may be necessary after approximately 6-12 months of storage to ensure consistent experimental results.

What are the most effective methods for using IAA19 antibodies in co-immunoprecipitation assays?

Co-immunoprecipitation (co-IP) assays with IAA19 antibodies require careful optimization to maintain protein interactions while ensuring specific pulldown. Based on established protocols, researchers should:

• Extract total protein from plant tissues (such as Arabidopsis seedlings or Nicotiana benthamiana leaves) using a buffer containing: 50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 1 mM EDTA, 0.5% Triton-X 100, and 2% (v/v) glycerol .

• Consider the redox state of IAA19 protein when designing extraction conditions, as the search results indicate that IAA proteins can form multimers under oxidizing conditions. For redox-sensitive experiments, extraction buffers can be supplemented with either 10 mM DTT (reducing conditions) or 10 mM diamide (oxidizing conditions) .

• Incubate the protein extract with anti-IAA19 antibodies conjugated to magnetic beads (or protein A/G beads with unconjugated antibodies) for 30-60 minutes at 4°C on a rotating platform.

• Wash the beads thoroughly (at least 4 times) with cold IP buffer to remove non-specific interactions.

• Elute the immunocomplexes with 1× Laemmli buffer (with or without β-mercaptoethanol depending on whether redox state is being analyzed).

For interaction studies with ARF transcription factors or other partner proteins, co-expression systems in N. benthamiana have proven effective, with the inclusion of the P19 silencing suppressor to enhance protein expression .

How can IAA19 antibodies be used effectively in chromatin immunoprecipitation (ChIP) assays?

For successful ChIP assays with IAA19 antibodies, researchers should follow these methodological guidelines:

• Crosslink plant tissue (preferably young seedlings for higher IAA19 expression) with 1% formaldehyde for 10-15 minutes, followed by quenching with glycine.

• Extract and sonicate chromatin to achieve DNA fragments of approximately 200-500 bp.

• Pre-clear the chromatin with protein A/G beads before incubation with IAA19 antibodies to reduce background.

• Incubate chromatin with IAA19 antibodies overnight at 4°C, following similar approaches to those used successfully with other plant transcription factors like CBF1-YFP and DREB2A-Ypet-His-FLAG .

• For IAA19, which functions as a transcriptional repressor, focus analysis on auxin-responsive genes containing auxin response elements (AuxREs).

• Include appropriate controls such as IgG antibodies and input samples.

• After reverse crosslinking and DNA purification, analyze the enrichment of target sequences using qPCR or sequencing.

For ChIP experiments investigating IAA19 binding under stress conditions, consider treatments that alter IAA19 stability or activity, such as auxin treatment or abiotic stress exposure. The effectiveness of IAA19 ChIP assays may be enhanced by using epitope-tagged versions of IAA19 (such as IAA19-YPet) expressed under native promoters .

What is the optimal protocol for Western blot detection of IAA19 protein?

For optimal Western blot detection of IAA19 protein, researchers should:

• Extract total protein using a buffer containing protease inhibitors to prevent degradation of Aux/IAA proteins, which are known to be unstable.

• For redox-sensitive analysis, prepare samples in non-reducing conditions by using Laemmli buffer without β-mercaptoethanol to preserve potential disulfide bonds .

• Separate proteins on a 10% SDS-PAGE gel, which provides good resolution for the IAA19 protein (approximately 22-25 kDa).

• Transfer proteins to a PVDF or nitrocellulose membrane using semi-dry or wet transfer methods (80-100V for 60-90 minutes).

• Block the membrane with 5% non-fat dry milk in TBST buffer for 1 hour at room temperature.

• Incubate with primary IAA19 antibody at the optimal dilution (typically 1:1000 to 1:5000) overnight at 4°C.

• Wash the membrane thoroughly with TBST (3-4 times, 5-10 minutes each).

• Incubate with appropriate HRP-conjugated secondary antibody for 1 hour at room temperature.

• Develop using chemiluminescence detection.

For experiments examining IAA19 stability under different conditions, include MG132 (proteasome inhibitor) in some samples to prevent degradation, allowing comparison of protein levels with and without proteasomal degradation. When analyzing post-translational modifications or redox states of IAA19, consider comparing reducing and non-reducing conditions in parallel samples .

How can researchers overcome cross-reactivity with other Aux/IAA proteins when using IAA19 antibodies?

Cross-reactivity with other Aux/IAA family members presents a significant challenge when working with IAA19 antibodies. To overcome this issue:

What strategies can help detect low-abundance IAA19 protein in plant tissues?

IAA19, like other Aux/IAA proteins, is often expressed at low levels and has a short half-life due to auxin-induced degradation. To enhance detection:

• Use protein concentration methods like TCA precipitation or acetone precipitation before gel loading to increase the amount of total protein that can be analyzed.

• Employ more sensitive detection systems such as enhanced chemiluminescence (ECL) with extended exposure times or fluorescent secondary antibodies with digital imaging.

• Consider tissue-specific or developmental stage-specific sampling, focusing on tissues where IAA19 expression is highest (often young, actively growing tissues or specific root zones).

• Pretreat plants with proteasome inhibitors (such as MG132) for 2-4 hours before harvesting to prevent IAA19 degradation and enhance detection .

• Enrich IAA19 using immunoprecipitation before Western blot analysis.

• For experiments requiring quantitative analysis of low-abundance IAA19, consider using HPLC or mass spectrometry-based methods which may offer greater sensitivity than antibody-based detection.

• When studying auxin responses, remember that treatment timing is critical – IAA19 levels may initially decrease after auxin treatment due to increased degradation before transcriptional upregulation takes effect.

What are the common pitfalls when studying IAA19 protein multimerization using antibodies?

The study of IAA19 protein multimerization presents several technical challenges that researchers should address:

• Redox sensitivity: IAA19 and other Aux/IAA proteins can form multimers under oxidizing conditions through cysteine residues . To accurately assess multimerization:

  • Maintain consistent redox conditions throughout sample preparation

  • Compare results under reducing (DTT) and oxidizing (diamide) conditions

  • Use non-reducing SDS-PAGE for analyzing multimeric forms

• Sample preparation artifacts: Artificial multimerization or disruption of multimers can occur during extraction. To minimize this:

  • Use appropriate buffer conditions with controlled redox state

  • Process samples quickly and consistently

  • Include controls with recombinant proteins treated under defined redox conditions

• Antibody limitations: Some antibodies may recognize epitopes that become inaccessible in multimeric forms. To address this:

  • Validate antibodies against known monomeric and multimeric forms

  • Consider using multiple antibodies targeting different epitopes

  • Complement antibody detection with size exclusion chromatography or native gel electrophoresis

• For studying cysteine-dependent multimerization similar to what has been observed with IAA3/SHY2 , researchers should consider preparing cysteine-to-serine mutant versions of IAA19 as controls to confirm redox-dependent interactions.

• To distinguish between homo- and hetero-multimerization (with other Aux/IAAs or ARFs), use differentially tagged versions of proteins and sequential immunoprecipitation approaches.

How can IAA19 antibodies be used to investigate stress-induced changes in auxin signaling pathways?

IAA19 antibodies can provide valuable insights into stress-induced changes in auxin signaling through the following approaches:

• Time-course experiments measuring IAA19 protein levels before and after stress treatments (e.g., drought, cold, salt stress). The search results indicate that IAA19 expression is regulated by DREB/CBF transcription factors in response to stress , making it an excellent marker for stress-induced auxin signaling changes.

• Comparative analysis of IAA19 protein levels and post-translational modifications across different stress conditions and plant tissues. This can be accomplished through:

  • Western blotting with phospho-specific or redox-state-specific antibodies

  • Immunoprecipitation followed by mass spectrometry to identify post-translational modifications

  • Co-immunoprecipitation to assess stress-induced changes in protein interaction partners

• ChIP-seq experiments using IAA19 antibodies to map genome-wide changes in IAA19 binding sites under different stress conditions, revealing stress-responsive gene regulatory networks.

• For studying the connection between ROS signaling and IAA19 function, researchers can examine IAA19 multimerization under oxidative stress conditions using non-reducing SDS-PAGE and Western blotting, similar to approaches used with IAA3/SHY2 .

• Spatial analysis using immunohistochemistry or fluorescent protein fusions to visualize changes in IAA19 localization and abundance in specific cell types during stress responses.

When designing such experiments, it's important to consider that stress responses often involve complex signaling networks with temporal dynamics. Therefore, careful time-course analysis and integration of transcriptomic and proteomic data with IAA19 protein analysis will provide the most comprehensive understanding.

What methodological approaches can determine if IAA19 forms heterodimers with other Aux/IAA proteins?

To investigate whether IAA19 forms heterodimers with other Aux/IAA proteins, researchers can employ several complementary methodologies:

• Co-immunoprecipitation with dual-tagged proteins:

  • Express IAA19 with one tag (e.g., HA-IAA19) and another Aux/IAA protein with a different tag (e.g., GFP-IAA5)

  • Perform immunoprecipitation with one antibody and detect with the other

  • Include appropriate controls such as single-expressed proteins

• Bimolecular Fluorescence Complementation (BiFC):

  • Fuse IAA19 and potential partner Aux/IAAs to complementary fragments of a fluorescent protein

  • Co-express in plant cells (N. benthamiana leaves or Arabidopsis protoplasts)

  • Visualize reconstituted fluorescence indicating protein-protein interaction

  • Include controls with mutated interaction domains

• Förster Resonance Energy Transfer (FRET):

  • Create fluorescent protein fusions of IAA19 and candidate partner proteins

  • Measure energy transfer between fluorophores when proteins interact

  • This approach allows real-time monitoring of interactions in living cells

• Redox-dependent interaction analysis:

  • Compare heterodimerization under reducing and oxidizing conditions

  • Use non-reducing SDS-PAGE to preserve disulfide-dependent interactions

  • Create cysteine-to-serine mutants to identify redox-sensitive residues

• Size Exclusion Chromatography with Multi-Angle Light Scattering (SEC-MALS):

  • Analyze purified recombinant proteins to determine the molecular weight of complexes

  • Compare observed molecular weights with theoretical values for homo- and heterodimers

• For in-depth analysis, combine protein interaction studies with functional assays using reporter genes to assess the transcriptional repression activity of different Aux/IAA heterodimers, as demonstrated with IAA7, IAA17, and IAA19 domain mutants .

How can researchers use IAA19 antibodies to study the dynamics of auxin-induced protein degradation?

IAA19 antibodies can be instrumental in investigating the dynamics of auxin-induced protein degradation through the following methodological approaches:

• Pulse-chase experiments:

  • Treat plants with proteasome inhibitors (MG132) to allow IAA19 accumulation

  • Remove inhibitor and add auxin

  • Collect samples at defined time intervals and analyze IAA19 protein levels by Western blotting

  • Calculate protein half-life under different auxin concentrations or in different genetic backgrounds

• Quantitative Western blotting:

  • Use internal loading controls and standard curves with recombinant protein

  • Analyze IAA19 degradation kinetics in response to different auxin concentrations or types

  • Compare wild-type IAA19 with domain II mutants that show altered stability

• Fluorescence microscopy with translational fusions:

  • Create IAA19-fluorescent protein fusions expressed under native promoters

  • Monitor fluorescence intensity over time after auxin treatment

  • This approach allows cell-type specific and subcellular analysis of degradation dynamics

• Co-immunoprecipitation time course:

  • Analyze the dynamics of IAA19 interaction with TIR1/AFB auxin receptors after auxin treatment

  • Monitor ubiquitination status of IAA19 using anti-ubiquitin antibodies after IAA19 immunoprecipitation

  • This provides mechanistic insights into the degradation process

• Comparison across tissues and developmental stages:

  • Analyze tissue-specific differences in IAA19 degradation rates

  • Correlate with expression levels of TIR1/AFB receptors and other components of the auxin signaling machinery

When designing such experiments, researchers should consider that IAA19, like other Aux/IAA proteins, contains a degron sequence in domain II that mediates auxin-induced degradation . Mutations in this domain, as documented in the literature, can significantly alter protein stability and serve as valuable controls.

How should researchers interpret differences in IAA19 protein levels versus transcript levels?

The interpretation of discrepancies between IAA19 protein and transcript levels requires careful consideration of several factors:

• Post-transcriptional and post-translational regulation:

  • Aux/IAA proteins including IAA19 are subject to rapid auxin-induced degradation through the ubiquitin-proteasome system

  • High transcript levels may not correlate with high protein levels due to rapid protein turnover

  • Create a table comparing IAA19 transcript and protein half-lives under different conditions

• Experimental design considerations:

  • When comparing transcript (via qRT-PCR) and protein levels (via Western blotting), ensure samples are taken from the same tissues at the same time points

  • Include proteasome inhibitor (MG132) treated samples as controls to reveal the "potential" protein level without degradation

  • Consider the sensitivity differences between RNA and protein detection methods

• Interpretation framework:

  • Increased transcript with unchanged protein: Suggests enhanced protein turnover

  • Increased protein with unchanged transcript: Suggests post-translational stabilization

  • Both increased but to different degrees: Indicates combined transcriptional and post-translational regulation

• For comprehensive analysis, consider measuring:

  • Total IAA19 transcript levels (qRT-PCR)

  • IAA19 protein levels (Western blot)

  • IAA19 protein synthesis rates (pulse labeling)

  • IAA19 protein degradation rates (cycloheximide chase)

  • Ubiquitination status of IAA19 (immunoprecipitation followed by ubiquitin detection)

• Remember that IAA19 is part of a feedback loop where auxin induces its transcription while simultaneously promoting its protein degradation . This complex regulation often leads to non-intuitive relationships between transcript and protein levels.

What controls and normalizations are essential when quantifying IAA19 protein across different experimental conditions?

Proper controls and normalizations are critical for reliable quantification of IAA19 protein across experimental conditions:

• Essential sample controls:

  • Positive control: Recombinant IAA19 protein at known concentrations for standard curve generation

  • Negative control: Protein extract from iaa19 knockout/knockdown plants

  • Treatment control: Samples treated with proteasome inhibitors to reveal maximum potential IAA19 levels

  • Loading control: Consistent total protein loading verified by Ponceau S staining or housekeeping proteins

• Normalization approaches:

  • Total protein normalization: Quantify IAA19 relative to total protein measured by Bradford assay or stain-free technology

  • Internal reference proteins: Use stable reference proteins such as actin, tubulin, or GAPDH, verifying their stability under your experimental conditions

  • Spike-in controls: Add known amounts of tagged recombinant IAA19 to samples for absolute quantification

• Technical considerations:

  • Use the linear range of detection for antibody-based quantification

  • Perform biological replicates (minimum n=3) and technical replicates

  • Ensure consistent sample processing (extraction buffer, incubation times, etc.)

  • Include a dilution series to verify detection linearity

• Data presentation:

  • Present normalized values with appropriate statistical analysis

  • Include both representative blots and quantification graphs

  • Clearly state normalization method in figure legends

• For experiments involving stress conditions or hormone treatments, verify the stability of your chosen reference proteins under these conditions, as many "housekeeping" proteins can be affected by stress treatments.

How can researchers design experiments to distinguish between IAA19's direct and indirect effects on gene expression?

Distinguishing between direct and indirect effects of IAA19 on gene expression requires sophisticated experimental design:

• Temporal analysis approaches:

  • Use inducible systems (such as β-Estradiol inducible promoters ) to control IAA19 expression

  • Perform time-course analysis following induction to identify immediate early response genes (likely direct targets) versus delayed response genes (likely indirect targets)

  • Combined with cycloheximide treatment to block de novo protein synthesis, revealing primary transcriptional responses

• Chromatin immunoprecipitation (ChIP) strategies:

  • Perform ChIP-seq with IAA19 antibodies to identify genome-wide binding sites

  • Correlate binding data with transcriptional changes identified by RNA-seq

  • Genes that show both IAA19 binding and expression changes are likely direct targets

  • Design appropriate controls including input chromatin and IgG immunoprecipitation

• Domain mutation analysis:

  • Compare transcriptional effects of wild-type IAA19 versus domain I mutants with reduced repressor activity

  • Genes affected by wild-type but not domain I mutants likely represent direct repression targets

  • Create table comparing gene expression changes induced by different IAA19 variants

• Auxin receptor mutant analysis:

  • Compare IAA19-dependent gene expression changes in wild-type versus tir1/afb mutant backgrounds

  • This helps distinguish between auxin-dependent and auxin-independent functions of IAA19

• Integration with ARF binding data:

  • Since IAA19 functions by interacting with ARF transcription factors , correlate IAA19-dependent gene expression changes with known ARF binding sites

  • Genes regulated by both IAA19 and ARFs are likely direct targets of the IAA19-ARF regulatory module

• For advanced analysis, consider the following experimental design:

  • Create an inducible system for expressing a stabilized IAA19 variant (domain II mutant)

  • Perform RNA-seq after short induction periods (30 min, 1 hour, 2 hours)

  • In parallel, perform ChIP-seq for IAA19 binding

  • Categorize genes as: bound and regulated (direct targets), bound but not regulated (potential targets), regulated but not bound (indirect targets)

How can IAA19 antibodies be used to investigate redox regulation of auxin signaling?

Recent research has revealed that Aux/IAA proteins, including IAA19, may be regulated by redox conditions . To investigate this emerging area:

• Comparative analysis under different redox states:

  • Analyze IAA19 protein multimerization under reducing versus oxidizing conditions using non-reducing SDS-PAGE

  • Perform immunoprecipitation under controlled redox states to identify redox-sensitive protein interactions

  • Compare with IAA3/SHY2, which has been shown to form ROS-dependent multimers

• Identification of redox-sensitive cysteine residues:

  • Create cysteine-to-serine mutants of IAA19 similar to the IAA3/SHY2-4C/S mutant

  • Analyze the impact of these mutations on multimerization, protein-protein interactions, and transcriptional repression activity

  • Use mass spectrometry to identify oxidative modifications on specific cysteine residues

• Integration with stress signaling:

  • Examine how ROS-generating stresses affect IAA19 multimerization and function

  • Investigate potential cross-talk between auxin and ROS signaling mediated by IAA19

  • Analyze IAA19 redox state during developmental processes known to involve ROS signaling

• Analysis of dimerization partner selectivity:

  • Determine if redox state affects the preference of IAA19 for homodimerization versus heterodimerization with ARFs or other Aux/IAAs

  • Use co-immunoprecipitation under different redox conditions to identify condition-specific interaction partners

• Functional consequences:

  • Compare the transcriptional repression activity of IAA19 under different redox conditions

  • Analyze if redox state affects IAA19 subcellular localization or degradation kinetics

  • Investigate whether redox regulation provides a mechanism for auxin-independent regulation of IAA19 function

This research direction connects the established roles of IAA19 in auxin signaling with emerging understanding of ROS as signaling molecules in stress responses and development .

What approaches can help investigate the role of IAA19 in stress response pathways?

The search results indicate that IAA19 is regulated by stress-responsive transcription factors like DREB/CBFs , suggesting an important role in stress responses. To investigate this function:

• Comparative phenotypic analysis:

  • Analyze stress responses in iaa19 mutants versus wild-type plants

  • Create gain-of-function lines expressing stabilized IAA19 (domain II mutants)

  • Examine stress tolerance phenotypes under drought, cold, salt, and other abiotic stresses

• Transcriptional network analysis:

  • Perform RNA-seq comparing wild-type and iaa19 mutants under control and stress conditions

  • Identify IAA19-dependent stress-responsive genes

  • Integrate with ChIP-seq data to distinguish direct and indirect targets

• Protein interaction dynamics:

  • Use co-immunoprecipitation with IAA19 antibodies to identify stress-specific interaction partners

  • Analyze how stress affects IAA19 interactions with ARFs and other regulatory proteins

  • Examine post-translational modifications of IAA19 under stress conditions

• DREB/CBF-IAA19 regulatory module analysis:

  • Investigate how DREB/CBF transcription factors regulate IAA19 expression under stress

  • Analyze IAA19 protein levels in cbf mutant backgrounds under stress conditions

  • Determine if IAA19 mediates cross-talk between auxin and stress signaling pathways

• Tissue-specific analysis:

  • Use tissue-specific promoters (such as CASP1 and GATA23 ) to express IAA19 variants

  • Analyze tissue-specific effects of IAA19 on stress responses

  • Perform cell-type specific transcriptome analysis to identify context-dependent IAA19 functions

• Root architecture responses:

  • Given that IAA19 is known to regulate lateral root development, analyze how stress-induced changes in IAA19 expression/stability affect root architecture

  • Investigate the role of IAA19 in xerobranching, an acclimative response where roots temporarily cease branching under water stress

This comprehensive approach will help elucidate how IAA19 integrates auxin signaling with stress response pathways to modulate plant development under challenging environmental conditions.

How can mass spectrometry complement antibody-based studies of IAA19?

Mass spectrometry (MS) provides powerful complementary approaches to antibody-based studies of IAA19, offering several advantages:

• Post-translational modification (PTM) mapping:

  • Identify specific PTMs on IAA19 (phosphorylation, ubiquitination, oxidation)

  • Quantify PTM changes under different treatments or conditions

  • This approach can reveal regulatory mechanisms not detectable by standard antibodies

  • Sample preparation should follow established protocols for PTM preservation

• Absolute quantification:

  • Use approaches like Selected Reaction Monitoring (SRM) or Parallel Reaction Monitoring (PRM)

  • Add isotopically labeled synthetic peptides as internal standards

  • This provides absolute quantification independent of antibody affinity

  • More reliable for comparing IAA19 levels across different experimental conditions

• Protein interaction network analysis:

  • Perform immunoprecipitation with IAA19 antibodies followed by MS analysis (IP-MS)

  • Identify novel interaction partners beyond known ARFs and Aux/IAAs

  • Compare interaction networks under different conditions (auxin treatment, stress, etc.)

  • Validate key interactions with targeted co-IP experiments

• Redox proteomics:

  • Apply techniques like OxiCAT or iodoTMT labeling to quantify oxidation states of cysteine residues in IAA19

  • Map specific cysteine residues involved in redox regulation

  • Compare with mutagenesis studies of cysteine residues

• Targeted MS assay development:

  • Develop specific SRM/PRM assays for IAA19-specific peptides

  • This allows detection of IAA19 even in complex samples or when antibodies show cross-reactivity

  • Particularly valuable for distinguishing between closely related Aux/IAA family members

Sample preparation for MS-based approaches should follow protocols similar to those described in the search results, including solution digestion using S-Trap columns and appropriate enzyme selection (trypsin or GluC) . Database searching should include appropriate variable modifications based on expected PTMs and experimental conditions.

When reporting MS-based results, include peptide coverage maps of IAA19 and specify which peptides were used for quantification or PTM identification, as this information is critical for assessing the reliability and comprehensiveness of the analysis.

How do mutations in IAA19 compare with mutations in other Aux/IAA family members?

Mutations in IAA19 and other Aux/IAA family members provide valuable insights into their distinctive and overlapping functions:

Key comparative insights:

• Domain II mutations typically result in stabilized proteins that constitutively repress auxin responses, but the severity and specificity of phenotypes vary based on the expression pattern and ARF interaction preferences of each Aux/IAA protein.

• Domain I mutations generally reduce repressor activity across family members, but with different molecular mechanisms - in IAA3/SHY2, mutations affect interaction with TPL co-repressor but not with ARF7 or TIR1 , while similar effects are observed with IAA7 and IAA17 .

• Redox sensitivity appears to vary among Aux/IAA family members , suggesting differential involvement in ROS-mediated signaling pathways.

• For comprehensive analysis of IAA19 function, researchers should compare phenotypes and molecular mechanisms with other family members, particularly those with similar expression patterns or stress responsiveness.

• When designing experiments to study specific functions of IAA19, consider potential functional redundancy with other Aux/IAA proteins and use higher-order mutants or tissue-specific approaches to overcome this challenge.

What strategies can help distinguish IAA19-specific effects from general auxin signaling disruption?

Distinguishing IAA19-specific effects from general disruption of auxin signaling requires strategic experimental approaches:

• Comparative genetic analysis:

  • Compare phenotypes of iaa19 mutants with mutations in other Aux/IAA genes and auxin signaling components

  • Use higher-order mutants to assess additive effects versus redundancy

  • Create domain-specific mutations rather than complete knockouts to target specific aspects of IAA19 function

• Tissue-specific approaches:

  • Use tissue-specific promoters to express wild-type or mutant IAA19 in defined cell types

  • Target tissues where IAA19 is predominantly expressed compared to other Aux/IAAs

  • The CASP1 and GATA23 promoters have been successfully used for similar approaches with IAA3/SHY2

• Developmental stage-specific analysis:

  • Focus on developmental processes or stress responses where IAA19 is specifically implicated

  • Design time-course experiments to capture IAA19-specific temporal dynamics

  • Use inducible systems to activate IAA19 expression/function at specific developmental stages

• Molecular specificity:

  • Identify and focus on genes specifically regulated by IAA19 but not other Aux/IAAs

  • Characterize IAA19-specific protein interactions

  • Investigate unique post-translational modifications or regulatory mechanisms

• Structure-function analysis:

  • Create chimeric proteins by swapping domains between IAA19 and other Aux/IAAs

  • Identify regions responsible for IAA19-specific functions

  • Generate point mutations targeting IAA19-specific amino acid residues, particularly in non-conserved regions

• For redox regulation studies, compare the cysteine content and positioning in IAA19 with other Aux/IAAs to identify potential differences in redox sensitivity, similar to the analysis performed for IAA3/SHY2 .

• When analyzing stress responses, focus on conditions where IAA19 shows distinctive expression patterns compared to other family members, particularly in relation to DREB/CBF regulation .

How can researchers integrate IAA19 protein data with transcriptomic and phenotypic data for comprehensive understanding?

Integrating IAA19 protein data with transcriptomic and phenotypic information requires systematic approaches:

• Multi-omics experimental design:

  • Collect samples for parallel analysis of:

    • IAA19 protein levels and modifications (using antibody-based methods)

    • Transcriptome analysis (RNA-seq)

    • Phenotypic measurements

  • Maintain consistent experimental conditions and timepoints across all analyses

  • Include appropriate genetic materials (wild-type, iaa19 mutants, overexpression lines)

• Data integration frameworks:

  • Develop correlation networks between IAA19 protein levels, transcript changes, and phenotypic effects

  • Use clustering approaches to identify gene modules co-regulated with IAA19

  • Apply machine learning methods to identify patterns connecting IAA19 protein status with downstream effects

• Temporal resolution:

  • Perform time-course analyses to establish causality

  • Create detailed timelines connecting changes in IAA19 protein with subsequent transcriptional and phenotypic responses

  • This is particularly important given the rapid turnover of Aux/IAA proteins and dynamic nature of auxin responses

• Spatial integration:

  • Combine cell-type specific or tissue-specific analyses of IAA19 protein with spatial transcriptomics

  • Correlate with tissue-specific phenotypes

  • Use techniques like INTACT (Isolation of Nuclei Tagged in specific Cell Types) combined with proteomics and transcriptomics

• Environmental context integration:

  • Analyze how environmental conditions affect the relationship between IAA19 protein, gene expression, and phenotypes

  • Particularly focus on stress conditions where IAA19 is regulated by DREB/CBF transcription factors

  • Examine how redox conditions affect IAA19 protein function and subsequent responses

• Network analysis:

  • Map IAA19 within broader signaling networks by integrating protein interaction data

  • Create signaling pathway models that connect IAA19 protein status to transcriptional changes and phenotypic outcomes

  • Identify feedback loops and regulatory circuits involving IAA19

• For comprehensive understanding of IAA19's role in stress responses, integrate:

  • Data on IAA19 protein dynamics under stress

  • Transcriptional responses regulated by IAA19

  • Changes in root architecture and other stress adaptation phenotypes

  • Interactions with stress-responsive transcription factors like DREB/CBFs